CN1236638A - Medical wine for treating rheumatism - Google Patents

Medical wine for treating rheumatism Download PDF

Info

Publication number
CN1236638A
CN1236638A CN99108175A CN99108175A CN1236638A CN 1236638 A CN1236638 A CN 1236638A CN 99108175 A CN99108175 A CN 99108175A CN 99108175 A CN99108175 A CN 99108175A CN 1236638 A CN1236638 A CN 1236638A
Authority
CN
China
Prior art keywords
gram
radix
treatment
medicated wine
soak
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN99108175A
Other languages
Chinese (zh)
Other versions
CN1079255C (en
Inventor
王建明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99108175A priority Critical patent/CN1079255C/en
Publication of CN1236638A publication Critical patent/CN1236638A/en
Application granted granted Critical
Publication of CN1079255C publication Critical patent/CN1079255C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

A medical wine for treating rheumatism is prepared through immersing tamariskoid spikemoss herb (30-50 g) and clematis root (20-30g) in (35-60% V/V) edible alcohol (2.5Kg), and features easily available raw materials and high near and far curative effect.

Description

A kind of medicated wine for the treatment of rheumatic Bi syndrome
The present invention relates to a kind of medicated wine for the treatment of rheumatic Bi syndrome.
At present, the medicated wine of more influential treatment rheumatic Bi syndrome Guogong liquor and Feng have been arranged property medicated wine on the market, the former main component is utilized the tibia infusion of animals on the brink of extinction, thereby its raw material sources are illegal; The latter is promptly effected a permanent cure based on late result, and drug effect is slow, the short term effect poor effect of promptly taking stopgap measures.
Purpose of the present invention just is to provide a kind of raw material easily to get, in the recent period and the medicated wine of the good treatment rheumatic Bi syndrome of late result.
The objective of the invention is to soak and comprise that dry product Herba Selaginellae, the made medicated wine of Radix Clematidis realizes by edible ethanol (35-60%v/v).Its prescription is: per 2.5 kilograms of soak with ethanol 30-50 gram Herba Selaginellae, 20-30 restrain Radix Clematidis.Herba Selaginellae, Radix Clematidis quality standard meet national Chinese crude drug dry product regulation.Radix Clematidis has the effect of stretching channels and activating collaterals, current meridians; In the Chinese medicine pharmacopeia, only put down in writing Herba Selaginellae and have the promoting blood circulation to restore menstrual flow effect, in fact Herba Selaginellae also has the good efficacy of controlling the wind damp eliminating, Herba Selaginellae and Radix Clematidis are used, can make the drug effect sick institute that goes directly, have invigorate blood circulation in the recent period wind damp eliminating, anti-inflammatory analgesic, dredge the meridian passage at a specified future date, the curative effect of repairing affected part, restore funcitons.
The present invention can be a main component with Herba Selaginellae, Radix Clematidis, and the following seven flavor dry product medical materials of compatibility constitute a complete medicated wine main formula:
Per 2.5 kilograms of edible ethanols (35-60%v/v) soak 10-20 gram Flos Carthami, 10-20 gram Olibanum, 10-20 gram Myrrha, 20-30 and restrains Zaocys, and 10-20 gram Rhizoma Atractylodis, 10-20 gram Rhizoma Et Radix Notopterygii, 10-20 restrain Radix Angelicae Pubescentis, 10-20 restrains Radix Gentianae Macrophyllae.
This main formula pays attention to being equipped with blood circulation promoting and enriching, the assistant medicine with QI invigorating controlling on the medication rule of wind, dampness, cold expelling, reaches the purpose of curing arthromyodynia according to the theory of the traditional Chinese medical science " control wind and control blood earlier, the blood sector-style is from going out ".
Cooperating main formula can also add following Six-element dry product medical material uses as auxilliary side:
Auxilliary side is: per 2.5 kilograms of soak with ethanol 10-20 gram Cortex Eucommiae, 10-20 gram Cortex Phellodendri, 10-20 gram Herba Epimedii, the 10-20 gram Radix Rehmanniae, the 20-30 gram Radix Astragali, 20-30 restrain Radix Angelicae Sinensis.More than this side have strengthening vital energy of kidney, the effect of the QI invigorating of invigorating blood circulation can be consolidated late result.
Herba Selaginellae, Radix Clematidis adopt per 2.5 kilograms of soak with ethanol 20-30 gram Ramulus Mori as the priming better effects if.
The present invention compares with the medicated wine of existing treatment rheumatic Bi syndrome, the raw material that it is got mostly is to adopt common herbaceous plant and common animal, easily purchase inexpensively, main component of the present invention in addition has current meridians, invigorates blood circulation and controls wind, stretch the effect of channels and activating collaterals, go up logical Baihui, pass through spring down, can reach the extremity bones of the body collectively, therefore evident in efficacy, instant effect; And has a late result of repairing affected part, restore funcitons.The present invention is according to the theoretical compatibility Cheng Fang of the traditional Chinese medical science " monarch ", and the profit agent that reusing in dry medicine enriches blood invigorates blood circulation makes dry not impairment of YIN, dispels the wind and QI invigorating, strengthen blood vessels and agitate, go out by wind, and real space between skin and muscles, refuse the exopathogen invasion, have treating both the principal and secondary aspects of a disease, control and support bonded advantage.But this medicated wine not only oral administration but also external are flexible and convenient to use.
By the following examples this utility model is further described.
The prescription of embodiment is as follows:
Embodiment 1 embodiment 2 embodiment 3 embodiment 4 edible ethanol 45%v/v 40%v/v 50%v/v 56%v/v
2.5 2.5 2.5 2.5 45 50 40 30 25 30 20 20 15 20 10 10 15 20 10 10 15 20 10 10 25 30 20 20 15 20 10 10 15 20 10 10 15 20 10 10 15 20 10 10 / 20 15 15 / 20 10 10 / 20 10 10 / 20 15 15 / 30 30 30 / 30 20 20 / 30 20 20。
/
Each embodiment all uses interior dose with disposable being immersed in the edible ethanol of each flavor medicine for the patient after 20 days: every day twice, each 10-30ml; External morning and evening every day respectively once is coated with and puts affected part on the skin, and each 5-10ml uses curative effect to see the following form: 1, interior month:
The course of treatment Arthritis Rheumatoid disease Sciatica
Embodiment 1 ????1000ml Obvious effective rate ???85% ????80% ????85%
Cure rate ???75% ????70% ????75%
Embodiment 2 ????1000ml Obvious effective rate ???98% ????98% ????98%
Cure rate ???95% ????80%?? ????90%
Embodiment 3 ????1000ml Obvious effective rate ???95% ????95% ????95%
Cure rate ???85% ????80% ????85%
Embodiment 4 ????1000ml Obvious effective rate ???95% ????95% ????95%
Cure rate ???85% ????80% ????85%
2, external
The course of treatment Arthritis Rheumatoid disease Sciatica
Embodiment 1 ??250ml Obvious effective rate ???75% ???70% ????75%
Cure rate ???65% ???60% ????65%
Embodiment 2 ??250ml Obvious effective rate ???85% ???80% ????85%
Cure rate ???75% ???70% ????75%
Above medicated wine can carry out by oral administration and externally simultaneously, its better efficacy.After the course of treatment, take 1-2 again and can consolidate curative effect the course of treatment.

Claims (4)

1, a kind of medicated wine for the treatment of rheumatic Bi syndrome soaks by edible ethanol (35-60% v/v) and to comprise that dry product Herba Selaginellae, Radix Clematidis are made, it is characterized in that:
Per 2.5 kilograms of soak with ethanol 30-50 gram Herba Selaginellae, 20-30 restrain Radix Clematidis.
2, a kind of medicated wine for the treatment of rheumatic Bi syndrome according to claim 1 is characterized in that:
Per 2.5 kilograms of edible ethanols soak 10-20 gram Flos Carthami, 10-20 gram Olibanum, 10-20 gram Myrrha, 20-30 and restrains Zaocys, and 10-20 gram Rhizoma Atractylodis, 10-20 gram Rhizoma Et Radix Notopterygii, 10-20 restrain Radix Angelicae Pubescentis, 10-20 restrains Radix Gentianae Macrophyllae.
3, a kind of medicated wine for the treatment of rheumatic Bi syndrome according to claim 1 is characterized in that:
Herba Selaginellae, Radix Clematidis adopt per 2.5 kilograms of soak with ethanol 20-30 gram Ramulus Mori as priming.
4, a kind of medicated wine for the treatment of rheumatic Bi syndrome according to claim 2 is characterized in that:
Per 2.5 kilograms of soak with ethanol 10-20 gram Cortex Eucommiae, 10-20 gram Cortex Phellodendri, 10-20 gram Herba Epimedii, the 10-20 gram Radix Rehmanniae, the 20-30 gram Radix Astragali, 20-30 restrain Radix Angelicae Sinensis.
CN99108175A 1999-06-11 1999-06-11 Medical wine for treating rheumatism Expired - Fee Related CN1079255C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99108175A CN1079255C (en) 1999-06-11 1999-06-11 Medical wine for treating rheumatism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99108175A CN1079255C (en) 1999-06-11 1999-06-11 Medical wine for treating rheumatism

Publications (2)

Publication Number Publication Date
CN1236638A true CN1236638A (en) 1999-12-01
CN1079255C CN1079255C (en) 2002-02-20

Family

ID=5273181

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99108175A Expired - Fee Related CN1079255C (en) 1999-06-11 1999-06-11 Medical wine for treating rheumatism

Country Status (1)

Country Link
CN (1) CN1079255C (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266398A (en) * 2011-07-07 2011-12-07 夏军秀 Composition for mud moxibustion of rheumatic diseases
CN103893309A (en) * 2013-11-28 2014-07-02 鹤壁职业技术学院 Medicament for treating rheumatoid arthritis
CN104435694A (en) * 2014-12-23 2015-03-25 李云祥 External traditional Chinese medicine medicated wine for treating rheumatism
CN104997838A (en) * 2015-07-31 2015-10-28 赵妙元 Rheumatism medical wine
CN108324875A (en) * 2018-05-09 2018-07-27 贵州苗缘医药科技有限公司 A kind of healthy medicated wine
CN109718281A (en) * 2019-03-23 2019-05-07 黑龙江中医药大学 A kind of traditional Chinese compound medicine that treating rheumatoid arthritis and preparation method
CN109793843A (en) * 2019-04-03 2019-05-24 陕西苗三爷昕时业医药管理有限公司 A kind of externally applied drug for treating rheumatism
CN110840978A (en) * 2018-08-02 2020-02-28 于金霞 A Chinese medicinal composition for treating rheumatic arthritis and rheumatoid arthritis, and medicated liquor containing the same
CN112220881A (en) * 2019-11-19 2021-01-15 于文娟 Formula and processing technology of health-care traditional Chinese medicine for treating rheumatic pain
CN115814040A (en) * 2022-12-12 2023-03-21 上海四十三度医疗科技有限公司 Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052639C (en) * 1994-02-02 2000-05-24 李庆和 Traditional Chinese medicine capsule for treating rheumatoid arthritis
CN1141801A (en) * 1996-04-26 1997-02-05 褚衍全 Medicine for treatment of rheumatism and hyperosteogeny
CN1147956A (en) * 1996-08-09 1997-04-23 赵奎祥 Medicine for treating rheumatoid disease
CN1056299C (en) * 1997-01-02 2000-09-13 宋守金 External application medicine for curing rheumatic and rheumatoid arthritis

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266398A (en) * 2011-07-07 2011-12-07 夏军秀 Composition for mud moxibustion of rheumatic diseases
CN102266398B (en) * 2011-07-07 2013-06-05 夏君秀 Composition for mud moxibustion of rheumatic diseases
CN103893309A (en) * 2013-11-28 2014-07-02 鹤壁职业技术学院 Medicament for treating rheumatoid arthritis
CN103893309B (en) * 2013-11-28 2015-12-09 鹤壁职业技术学院 A kind of medicine for the treatment of rheumatoid arthritis
CN104435694A (en) * 2014-12-23 2015-03-25 李云祥 External traditional Chinese medicine medicated wine for treating rheumatism
CN104997838A (en) * 2015-07-31 2015-10-28 赵妙元 Rheumatism medical wine
CN108324875A (en) * 2018-05-09 2018-07-27 贵州苗缘医药科技有限公司 A kind of healthy medicated wine
CN110840978A (en) * 2018-08-02 2020-02-28 于金霞 A Chinese medicinal composition for treating rheumatic arthritis and rheumatoid arthritis, and medicated liquor containing the same
CN109718281A (en) * 2019-03-23 2019-05-07 黑龙江中医药大学 A kind of traditional Chinese compound medicine that treating rheumatoid arthritis and preparation method
CN109718281B (en) * 2019-03-23 2021-06-15 黑龙江中医药大学 Traditional Chinese medicine compound medicine for treating rheumatoid arthritis and preparation method
CN109793843A (en) * 2019-04-03 2019-05-24 陕西苗三爷昕时业医药管理有限公司 A kind of externally applied drug for treating rheumatism
CN112220881A (en) * 2019-11-19 2021-01-15 于文娟 Formula and processing technology of health-care traditional Chinese medicine for treating rheumatic pain
CN115814040A (en) * 2022-12-12 2023-03-21 上海四十三度医疗科技有限公司 Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation thereof

Also Published As

Publication number Publication date
CN1079255C (en) 2002-02-20

Similar Documents

Publication Publication Date Title
CN1068218C (en) Adhesive plaster for curing prolapse of lumbar intervertebral disk
CN1079255C (en) Medical wine for treating rheumatism
CN1047090C (en) Plaster for curing cough with dyspnea
CN101391056B (en) Medicine for treating aplastic anemia
CN101073616A (en) Compound nebula for treating rhinitis
CN1478526A (en) Pure medicated wine
CN112915142B (en) Traditional Chinese medicine scraping medium and preparation method thereof
CN101214351A (en) Medicament for treating Tourette syndrome
CN1056762C (en) Brain-refreshing analgesic powder medicine
CN101530598B (en) Plaster used for hyperosteogeny
CN101214326B (en) External medicament for treating acne
CN101569686A (en) Hair growing hair follicle injection liquid
CN1061252C (en) Preparation of Chinese medicine for curing cardiac and cerebral diseases atomized by oxygen and its preparation process
CN1117583C (en) Medicine for curing lumbago
CN1814241A (en) Toxin-elimination health-care medicine composition
CN1184975C (en) Medicine for treating obsessional neurosis via head acupoint osmosis
CN1058889C (en) External-use ointment for treating atrophic arthritis
CN1292288A (en) Kechuantong
CN1309403C (en) Medicinal wine having therapeutic functions for scapulohumeral periarthritis, arthritis and pains of arms and legs
CN102000154B (en) Fumigating ointment for treating leucoderma and preparation method
CN104922339A (en) Traditional Chinese medicine bath composition and preparation method thereof
CN103041187B (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis by oral medication
CN1065437C (en) Traditional Chinese medicine prescription for treating ischialgia disease
CN1095296A (en) Health-care medicine ball
CN1408393A (en) External-use traditional Chinese medicine for curing chronic rhinitis, nasosinusitis and laryngopharyngitis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee